Correlation Between Syndax Pharmaceuticals and Verona Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Verona Pharma PLC, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Verona Pharma.

Diversification Opportunities for Syndax Pharmaceuticals and Verona Pharma

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Syndax and Verona is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Verona Pharma go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and Verona Pharma

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 3.03 times less return on investment than Verona Pharma. But when comparing it to its historical volatility, Syndax Pharmaceuticals is 1.72 times less risky than Verona Pharma. It trades about 0.24 of its potential returns per unit of risk. Verona Pharma PLC is currently generating about 0.43 of returns per unit of risk over similar time horizon. If you would invest  1,500  in Verona Pharma PLC on April 22, 2024 and sell it today you would earn a total of  795.00  from holding Verona Pharma PLC or generate 53.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Syndax Pharmaceuticals  vs.  Verona Pharma PLC

 Performance 
       Timeline  
Syndax Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Syndax Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating fundamental indicators, Syndax Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in August 2024.
Verona Pharma PLC 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Syndax Pharmaceuticals and Verona Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Syndax Pharmaceuticals and Verona Pharma

The main advantage of trading using opposite Syndax Pharmaceuticals and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.
The idea behind Syndax Pharmaceuticals and Verona Pharma PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios